Pivmecillinam hydrochloride is primarily used as an antibiotic to treat bacterial infections, particularly those affecting the urinary tract. It is effective against a range of Gram-negative bacteria, including Escherichia coli, which is a common cause of urinary tract infections (UTIs). The compound works by inhibiting bacterial cell wall synthesis, leading to the destruction of the bacteria. It is often prescribed for uncomplicated lower UTIs and is suitable for both acute and recurrent infections. Due to its targeted action and low resistance rates, it is considered a reliable option in managing such infections. It is typically administered orally, making it convenient for outpatient treatment.